NCT03477838已完成不适用
A Pharmacist-driven Continuous Glucose Monitoring Program for Advanced Diabetes Management in an Uninsured Population
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Change in A1c
研究概览
简要总结
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult 18 years of age or older
- •diagnosis of Type 1 or Type 2 diabetes
- •A1c greater than 8%
- •prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1 (GLP-1) receptor agonist
排除标准
- •pregnant or breast-feeding
- •on dialysis
- •not appropriate for CGM use based on clinical judgment by the investigators
- •patients with limited English proficiency
结局指标
主要结局
Change in A1c
时间窗: Baseline to week 12
Change in A1c will be used to assess glycemic control
次要结局
- Medication Changes(Baseline to week 12)
- Glycemic Variability(Baseline to week 12)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management PlatformGlucose Metabolism DisordersDiabetes MellitusPreDiabetesNCT04369833Pusan National University Hospital130
已完成
1 期
Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)Type 2 Diabetes MellitusNCT01537120Merck Sharp & Dohme LLC25
已完成
不适用
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill PatientsCritical IllnessDiabetes MellitusHyperglycemiaHypoglycemiaNCT05442853Malcom Randall VA Medical Center85
招募中
不适用
Periodic Continuous Glucose Monitoring in Patients With Type 2 DiabetesType 2 DiabetesNCT05633628Sophiahemmet University400
已完成
2 期
Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 DiabetesType 2 DiabetesNCT00993824HealthPartners Institute21